Dezhan Healthcare is a leading healthcare brand that specializes in the pharmaceutical industry. With a focus on research, development, production, and sales, they offer a wide range of products in the field of chemical medicine, formulations, industrial cannabis, and bio-peptides. Their product portfolio includes drugs, vaccines, healthcare products, functional beverages, and cosmetics, catering to the needs of the wellness sector.

As a state-owned pharmaceutical company, Dezhan Healthcare is directly supervised by the Xinjiang Financial Investment (Group) Co., Ltd., a state-owned holding enterprise. Their market value is currently estimated at around 9 billion yuan. With a strong emphasis on innovation, Dezhan Healthcare has established itself as a pioneer in the field of cardiovascular and oncology drugs.

They have a team of over 200 experienced research professionals working across four specialized pharmaceutical research institutions. Committed to providing high-quality medication, Dezhan Healthcare aims to become a renowned pharmaceutical company that encompasses research, production, and marketing, ensuring the well-being of millions of patients and safeguarding public health